Proton Pump Inhibitors Market Outlook 2022 – Rising Demand, Share, Trends, Growth, Opportunities and Top Key 2022

Proton pump inhibitors are a group of drugs whose main function is a pronounced and long-lasting reduction of gastric acid secretion in the linings of the stomach. They irreversibly block the enzyme process that actively transports gastric acid from parietal cells to the gastrointestinal lumen in the form of hydrogen-potassium adenosine triphosphate (proton pump). Proton pump inhibitors are used to relieve the symptoms of gastro-oesophageal reflux diseases (GERD), gastritis, peptic ulcers, Dyspepsia, Barrett’s oesophagus, Gastrinomas and other conditions that cause hypersecretion of gastric acid.Proton pump inhibitors are among the most widely used medications in the world, with the first one, omeprazole, being on the WHO Model List of Essential Medicines.


Download free Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065081

Market Dynamics

Increasing consumer acceptance of novel drug delivery systems, launch of new products, increasing shift from prescription drugs to over-the-counter products, and rising prevalence of peptic ulcer and other gastro-intestinal disorders are the key factors propelling the growth of the market.Conversely, the increasing use of generic drugs hampers the market growth. Consumers in isolated and rural regions tend to prefer the common antacids to deal with ulcer & other gastro-intestinal conditions.

Market Segmentation

The global proton pump inhibitors market is fragmented mainly on the basis of the drug type.
Drug Type
Omeprazole
Rabeprazole
Pantoprazole
Lansoprazole
Dexlansoprazole
Esomeprazole
The patent license of drug Esomeprazole expired in the year 2015, which is the major reason for the likely domination of Omeprazole & Lansoprazole in the market during the forecast period.

Geographical Analysis

North America had the dominant market share in 2015, which is mainly attributed to a consistent launch of new products and a rapidly increasing prevalence of gastrointestinal disorders in the region. However, the Asia Pacific market is anticipated to grow at a higher CAGR in the forecast period. The Asia Pacific region is flooded with numerous gastrointestinal drug products in addition to a large patient pool with gastro intestinal problems. This creates a need for curative drugs and is expected to drive the market growth remarkably.

Download free Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065081

Key Players
Some of the prominent players dominating the proton pump Inhibitors market are AstraZeneca, Takeda Pharmaceuticals, Wyeth Pharmaceuticals, Eisai Pharmaceuticals India Pvt. Ltd., Teva Pharmaceuticals, Cadila Pharmaceuticals, Pfizer, Eli Lilly and Company, and Janssen Global Services, LLC.Many other companies in this field are adopting product enhancements and launches, acquisitions, and agreements as their key business strategies in order to top the global market.

Report ContentsRegional AnalysisReport Highlights
Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Russia
Poland
Rest of Eastern Europe

Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

Request For Full Report: https://www.kennethresearch.com/report-details/global-proton-pump-inhibitors-market/10065081 

About Us
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.

Contact Us
Kenneth Research
Email:Sales@kennethresearch.com
Phone:+1 313 462 0609

Eli is a freelance writer and possess double graduation degree in physics and chemistry. She is an intense writer covering everything for Science and Tech to Business, Entertainment, Sports and Lifestyle.

Leave a Reply